{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:21Z","timestamp":1786119381564,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1097\/mbc.0b013e328342486a","type":"journal-article","created":{"date-parts":[[2010,12,23]],"date-time":"2010-12-23T00:47:00Z","timestamp":1293065220000},"page":"144-147","source":"Crossref","is-referenced-by-count":15,"title":["Diagnosis and therapeutic management in a patient with type 2B-like acquired von Willebrand syndrome"],"prefix":"10.1097","volume":"22","author":[{"given":"Ralf","family":"Karger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Weippert-Kretschmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Kretschmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210203","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-0037-1613993","article-title":"Acquired von Willebrand syndrome: from pathophysiology to management","volume":"84","author":"Veyradier","year":"2000","journal-title":"Thromb Haemost"},{"key":"R2-13-20210203","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1182\/blood.V91.10.3623","article-title":"Clinical significance of inhibitors in acquired von Willebrand syndrome","volume":"91","author":"Mohri","year":"1998","journal-title":"Blood"},{"key":"R3-13-20210203","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1160\/TH04-03-0193","article-title":"Characterization of a myeloma patient with a life-threatening hemorrhagic diathesis: presence of a lambda dimer protein inhibiting shear-induced platelet aggregation by binding to the A I domain of von Willebrand factor","volume":"93","author":"Shinagawa","year":"2005","journal-title":"Thromb Haemost"},{"key":"R4-13-20210203","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood.V97.1.162","article-title":"Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions","volume":"97","author":"Dong","year":"2001","journal-title":"Blood"},{"key":"R5-13-20210203","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1160\/TH07-04-0279","article-title":"Von Willebrand factor: looking back and looking forward","volume":"98","author":"Ruggeri","year":"2007","journal-title":"Thromb Haemost"},{"key":"R6-13-20210203","first-page":"357","article-title":"Simulation of primary haemostasis in vitro","volume":"15","author":"Kratzer","year":"1985","journal-title":"Haemostasis"},{"issue":"Suppl 4","key":"R7-13-20210203","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2516.2004.00991.x","article-title":"Clinical diagnosis of von Willebrand disease","volume":"10","author":"Federici","year":"2004","journal-title":"Haemophilia"},{"key":"R8-13-20210203","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0038-1645215","article-title":"Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes","volume":"63","author":"Budde","year":"1990","journal-title":"Thromb Haemost"},{"key":"R9-13-20210203","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1160\/TH06-09-0495","article-title":"Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF(High Purity)] in people with von Willebrand disorder. A randomised cross-over, multicentre study","volume":"97","author":"Favaloro","year":"2007","journal-title":"Thromb Haemost"},{"key":"R10-13-20210203","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1160\/TH06-11-0672","article-title":"Type 2B von Willebrand disease in seven individuals from three different families: phenotypic and genotypic characterization","volume":"98","author":"Sz\u00e1nt\u00f3","year":"2007","journal-title":"Thromb Haemost"},{"key":"R11-13-20210203","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/ajcp\/92.4.471","article-title":"Absence of a bleeding tendency in severe acquired von Willebrand's disease","volume":"92","author":"Drouin","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"R12-13-20210203","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler","year":"1994","journal-title":"Thromb Haemost"},{"key":"R13-13-20210203","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood.V91.4.1325","article-title":"Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases","volume":"91","author":"Fressinaud","year":"1998","journal-title":"Blood"},{"key":"R14-13-20210203","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-0038-1660415","article-title":"Determination and treatment of disorders of primary haemostasis: experience with routine application of the in vitro bleeding test","volume":"19","author":"Kretschmer","year":"1999","journal-title":"H\u00e4mostaseologie"},{"key":"R15-13-20210203","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/09537100601100366","article-title":"Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a bleeding history: a systematic review and meta-analysis","volume":"18","author":"Karger","year":"2007","journal-title":"Platelets"},{"key":"R16-13-20210203","first-page":"905","article-title":"Von Willebrand disease: diagnosis, classification and treatment","author":"Sadler","year":"2006"},{"key":"R17-13-20210203","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1055\/s-0037-1613738","article-title":"A case of acquired von Willebrand syndrome successfully treated with recombinant factor VIIa during thyroidectomy (case report)","volume":"92","author":"Smaradottir","year":"2004","journal-title":"Thromb Haemost"},{"key":"R18-13-20210203","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1182\/blood.V91.10.3792","article-title":"Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor","volume":"91","author":"Depraetere","year":"1998","journal-title":"Blood"},{"key":"R19-13-20210203","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.10298","article-title":"Acquired von Willebrand's syndrome: a single institution experience","volume":"72","author":"Kumar","year":"2003","journal-title":"Am J Hematol"},{"key":"R20-13-20210203","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2516.1996.tb00018.x","article-title":"Desmopressin and type II B von Willebrand disease","volume":"2","author":"Castaman","year":"1996","journal-title":"Haemophilia"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MBC.0b013e328342486a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:01:32Z","timestamp":1786039292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-201103000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e328342486a","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}